Phenytoin

苯妥英

Report date: 2026/05/18 20:02:07
NME

Base Information

Drug NamePhenytoin
Drug Alias Name二苯妥因phenytoinum二苯乙内酰脲地仑丁地伦丁 +[10] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channel protein type V alpha subunit blockersSodium channel protein type I alpha subunit blockers
TargetsSodium channel protein type V alpha subunitSodium channel protein type I alpha subunit
Therapy Area/IndicationsWounds and InjuriesSeizuresEpilepsy, Tonic-Clonic +[7] 
Global Approved IndicationsSeizuresEpilepsy, Tonic-ClonicEpilepsy, Temporal Lobe +[4] 
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1953/01/06
Country/TerritoryUnited StatesEgyptJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesCairo UniversityPfizer IncMansoura University +[4] 
Inactive CompaniesNational Institutes Of Health Clinical Center (Cc)
Active IndicationsWounds and InjuriesSeizuresEpilepsy, Tonic-Clonic +[7] 
Inactive IndicationsN/A

Other Information

ATC CodeN03AB02
Related LinksWikipediaDrugBankKEGG